TP53 and cyclic hematopoiesis: While large studies of the longitudinal history of CH over the patient’s life span reported a slow growth rate of TP53 and PPM1D mutations in the absence of external stressors [49, 53, 54], our clonal fitness analysis points towards a strong selection of DDR-mutated clones over the course of study treatment.